Tessera Therapeutics
Donald Trump
Privacy Concerns
California
Volleyball
Watkins Fellowship
L.A. Jordan
Sacramento State
David Sandy
Ernestine Eckstein
Barbara Gittings
Tessera Therapeutics
Globe Newswire - Dec 18th, 2024
Tessera Therapeutics Receives Investment to Develop Curative In Vivo Genetic Treatment for Sickle Cell Disease
Investments of up to $50 million from the Bill & Melinda Gates Foundation to develop globally accessible in vivo genetic therapies for sickle cell disease Investments of up to $50 million from the Bill & Melinda Gates Foundation to develop globally accessible in vivo genetic therapies for sickle cell disease
Previous
Next
Showing 1 to 1 of 1 results